Major Events - Cathay Pacific (00293) has purchased fourteen Boeing 777-9 aircraft [1] - Hengrui Medicine (01276) received FDA orphan drug designation for the combination of injection Rituximab and chemotherapy for gastric cancer or gastroesophageal junction adenocarcinoma [1] - China National Pharmaceutical Group (01177) has its self-developed drug TQ05105 (JAK/ROCK inhibitor) included in the breakthrough therapy designation program [1] - Junshi Biosciences (02696) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanli Kang® for active glomerulonephritis in China [1] - YingTai Medical (01501) plans to invest no more than 110 million yuan to establish the Huai Ge Guang Tai Fund [1] - JinJing New Energy (01783) proposed a stock split [1] Financial Data - Cathay Pacific (00293) reported a mid-term profit attributable to shareholders of 3.651 billion HKD, a year-on-year increase of 1.1%, with an interim dividend of 0.2 HKD per share [1] - Uni-President Enterprises China (00220) reported a mid-term profit attributable to shareholders of 1.287 billion CNY, a year-on-year increase of 33.24% [1] - BeiGene (06160) reported a net profit of 94.32 million USD in the second quarter, returning to profitability year-on-year [1] - New World Development Company (00086) issued a profit warning, expecting mid-term profit attributable to shareholders to increase to no less than 800 million HKD year-on-year [1] - Weixin Jinkao (02003) issued a profit warning, expecting mid-term comprehensive net profit to be no less than 200 million CNY, a significant year-on-year increase [1] - ZhiZi Cheng Technology (09911) issued a profit warning, expecting mid-term profit attributable to shareholders to increase by approximately 108.9% to 126.7% year-on-year [1] - Huaxian Optoelectronics (00334) issued a profit warning, expecting a year-on-year increase of no less than 600% in profit attributable to the parent company [1] - Xinli International (00732) reported a total operating revenue of approximately 1.468 billion HKD in July, a year-on-year decrease of about 3.3% [1]

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Group 1 - The company expects to achieve a consolidated net profit of no less than RMB 200 million for the six months ending June 30, 2025, which represents an increase of at least 65% compared to the consolidated net profit of RMB 120.3 million for the same period last year [1] - The expected growth in consolidated net profit and adjusted consolidated net profit is primarily attributed to an increase in loan amounts during the period [1]

预期期内综合净利润以及综合经调整净利润的增长主要由于期内贷款额增加。 格隆汇8月6日丨维信金科(02003.HK)公布，集团预期于截至2025年6月30日止六个月将录得综合净利润 不少于人民币2亿元，以及综合经调整净利润不少于人民币2亿元，相较同期综合净利润为人民币1.203 亿元，以及综合经调整净利润人民币1.207亿元增长不少于65%。 ...

香港交易及結算所有限公司和香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何 聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 正 面 盈 利 預 告 本公告乃根據上市規則第 13.09 條及內幕消息條文作出。 董事會謹此通知股東、本公司其他證券的持有人以及潛在投資者，根據目前所得資 料及對本集團最新未經審核綜合管理賬目的初步評估，本集團預期於期內將錄得綜 合淨利潤不少於人民幣 200.0 百萬元，以及綜合經調整淨利潤(1)不少於人民幣 200.0 百萬元，相較同期綜合淨利潤為人民幣 120.3 百萬元，以及綜合經調整淨利 潤(1)人民幣 120.7 百萬元增長不少於 65%。 股東、本公司其他證券的持有人以及潛在投資者請留意，於買賣本公司證券時務須 審慎行事。 本公告乃由維信金科控股有限公司（「本公司」，連同其附屬公司統稱為「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 13.09 條和 香港法例第 571 章證券及期貨條例第 XIVA 部的內幕消息條文（定義見上市規則） 刊發。 本公司董事會（「董事會」 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 維信金科控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02003 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 489,459,789 | | 0 | | 489,459,789 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 489,459,789 | | 0 | | 489,459,789 | 第 2 頁 共 10 頁 v 1.1.1 | 1. 股份分類 | 普通股 | 股份類別 ...

Core Viewpoint - In 2024, the integration of digital economy and fintech is leading to a paradigm shift in consumer rights protection from passive defense to proactive governance, exemplified by Weixin Jinke's comprehensive consumer protection ecosystem driven by both technological and service capabilities [1] Group 1: Institutional Framework - Weixin Jinke continues to build a "4+12" consumer protection management system, optimizing regulations such as the Consumer Rights Protection Management System and Complaint Management System to enhance adaptability and effectiveness [3] Group 2: Business Integration - To better protect consumer rights, Weixin Jinke is enhancing the integration of consumer protection concepts with business operations through product experience optimization and standardized customer management [5][6] - Product experience optimization includes detailed displays of guarantee fees and the establishment of a hesitation period for first-time borrowers to safeguard consumer rights [5] Group 3: Security Enhancement - In 2024, Weixin Jinke's Information Security Management Committee is focusing on compliance, technical protection, monitoring, and anti-fraud efforts, achieving no data breach incidents throughout the year [8] - The company has received multiple industry certifications, including a one-star Personal Information Protection Impact Assessment (PIA) and a Data Security Management Capability Certification (DSMC) [8] Group 4: AI Empowerment - Weixin Jinke is leveraging AI to enhance service efficiency and warmth, introducing features like intelligent voice navigation and service progress tracking, achieving a 92% accuracy rate in customer demand recognition and a 25% increase in issue resolution within 24 hours [9] Group 5: Knowledge Dissemination - The company is committed to enhancing consumer self-protection capabilities through knowledge-sharing initiatives, conducting four consumer rights protection knowledge dissemination events reaching 600 participants and publishing nearly 200 educational articles [11] - The "Weixin People's Daily on Consumer Protection" video series and the consumer protection classroom on the DouDouQian platform have engaged over 90,000 users, contributing to a safer and healthier consumption ecosystem [11] Group 6: Social Responsibility - Weixin Jinke prioritizes consumer rights protection as a core aspect of corporate social responsibility, especially during natural disasters and public emergencies, establishing emergency service mechanisms and compassionate policies for affected users [13] - The company's practices in 2024 demonstrate that true consumer protection innovation requires the organic integration of institutional frameworks, technological defenses, and service warmth [13]

Group 1 - The core viewpoint of the article highlights the commitment of Weixin Jinke to public welfare through the "100 Reading Corners Project," which aims to enhance reading resources in rural schools across China [1][2]. - The project has successfully donated over 20,000 books to 100 rural primary schools in 23 provinces, addressing the significant disparity in reading resources between urban and rural children [1][2]. - The reading rate among minors has increased from 77% in 2012 to 86.2% in 2023, with the average number of books read per person rising from 5.49 to 11.39, indicating a growing interest in reading among children [1]. Group 2 - The "100 Reading Corners Project" received applications from 471 classes nationwide in its first phase, ultimately donating over 10,000 books to 50 rural primary schools in 21 provinces, demonstrating a strong response to the urgent needs of rural education [2]. - Firefly Public Welfare has reached over 7,000 schools and benefited 5 million rural students through various initiatives, showcasing the extensive impact of the program [2]. - Weixin Jinke plans to continue optimizing project mechanisms and deepen collaborations with organizations like Firefly Public Welfare, exploring diverse educational support paths and leveraging technology to enhance public welfare [3].

Group 1 - Jianbang High-Tech submitted its listing application to the Hong Kong Stock Exchange, focusing on silver powder production for photovoltaic silver paste, with 2024 revenue of approximately 3.95 billion yuan, a year-on-year increase of 41.99% [1] - The company reported a gross profit of 131 million yuan, up 21.96% year-on-year, and a net profit of about 79 million yuan, reflecting a 31.95% increase [1] - Jianbang High-Tech aims to leverage its listing opportunity to expand its market presence and enhance competitiveness in the photovoltaic silver powder sector [1] Group 2 - Weixin Jinke announced that its minimum public shareholding has been restored, with approximately 163 million shares held by the public, accounting for 33.34% of total issued shares [2] - This restoration is crucial for maintaining the company's listing status and enhancing market confidence [2] - The company needs to continue monitoring its public shareholding to comply with relevant regulations and improve business performance [2] Group 3 - Weihong Group Holdings announced a further delay in publishing its 2024 annual results, now expected on May 12, due to incomplete bank confirmations and valuation reports [3] - The company's shares have been suspended from trading since April 1, 2024, indicating significant challenges in financial reporting [3] - The uncertainty surrounding the financial data may affect investor confidence and market perception of the company's financial health [3] Group 4 - China Longgong reported investments in various wealth management products, with unredeemed principal amounts of approximately 1.246 billion yuan in Bank of China products, 1.126 billion yuan in CCB products, 620 million yuan in CITIC products, and 410 million yuan in Minsheng products [4] - This diversified investment strategy reflects the company's cautious approach to fund management and risk diversification [4] - However, the high unredeemed principal amounts indicate potential market and liquidity risks that investors should monitor [4] Group 5 - Xunzhong Co., a new third board innovative layer enterprise, submitted its listing application to the Hong Kong Stock Exchange, previously having filed a prospectus on July 26, 2024 [5] - The company is positioned as a leading provider of intelligent cloud communication services, holding a 1.8% market share in China's cloud communication service market in 2023 [5] - The renewed listing application demonstrates the company's commitment to expanding its international market presence and enhancing its competitiveness in the global cloud communication sector [5] Group 6 - The Hang Seng Index closed at 22,504.68, with a gain of 1.74% on May 2 [6] - The Hang Seng Tech Index rose by 3.08%, closing at 5,244.06 [6] - The National Enterprises Index increased by 1.92%, ending at 8,231.04 [6]

Financial Performance - In 2024, the company achieved robust operational results and financial performance, benefiting from China's economic stimulus policies introduced in September 2024[8]. - The total revenue for 2024 was RMB 39.297 billion, an increase of 10.1% from RMB 35.695 billion in 2023[22]. - Net profit and adjusted net profit for 2024 were RMB 4.782 billion and RMB 4.787 billion, respectively, reflecting increases of 5.3% and 5.1% compared to RMB 4.539 billion and RMB 4.556 billion in 2023[23]. - Operating profit for the year was RMB 636.2 million, a 5.2% increase from RMB 604.8 million in 2023[28]. - Net profit for the year was RMB 478.2 million, up 5.3% from RMB 453.9 million in the previous year[28]. - Total revenue increased by 10.1% to RMB 3,929.7 million from RMB 3,569.5 million year-on-year, driven by higher average outstanding loan balances and increased contributions from other income sources[49]. - Interest and similar income rose by 33.2% to RMB 1,968.2 million, compared to RMB 1,477.3 million in the previous year[28]. - The overdue rate for new loans in mainland China stabilized at 0.58% in Q4 2024, an 18.3% decrease year-on-year[17]. - The loan facilitation model contributed to a total loan amount of RMB 43.03 billion, accounting for 77.2% of the total loan amount realized[19]. Customer and Market Development - The company continues to transition towards higher-quality borrowers, enhancing credit risk models and improving identification and classification accuracy of new quality customer segments[9]. - The cumulative registered users in mainland China reached 158 million by December 31, 2024, representing a year-on-year growth of 9.7%[18]. - The proportion of repeat borrowers accounted for 85.9% of the total loan volume in 2024[33]. - The company launched the "CreFIT Cash Loan" product in July 2024, providing convenient and flexible short-term financing solutions, demonstrating its commitment to financial innovation[11]. - The company established a partnership with China Mobile Hong Kong in May 2024, becoming the first lending institution in the region to strengthen customer acquisition channels[11]. Risk Management and Compliance - The company emphasizes compliance with regulatory requirements, maintaining constructive dialogue with regulators to ensure operational strategies align with evolving regulations[10]. - The company plans to enhance compliance management and consumer protection through a newly established Consumer Protection Committee[24]. - The overdue rates for one to three months and over three months decreased to 3.39% and 3.02% respectively in Q4 2024 due to enhanced risk control measures[40]. - The company has implemented a risk management framework that includes a risk management committee composed of senior management[152]. - The board is responsible for maintaining an effective risk management and internal control system, addressing various risks including credit and liquidity risks[149]. Operational Efficiency and Technology - The company reported continuous improvement in operational efficiency and profit structure through the integration of AI technology with risk control models[8]. - The company is actively exploring generative AI technology to improve operational efficiency and user experience[20]. - The launch of the AI model "Jinwu" aims to enhance customer service quality and operational efficiency across various business areas[32]. - The company utilizes a proprietary technology called "Hummingbird" for online processing of loan applications, which includes credit assessments and fraud detection[154]. - The company reassesses the creditworthiness of existing customers monthly using a behavioral scoring model, tracking overdue payment rates[154]. Corporate Governance - The board of directors is committed to adopting good corporate governance practices and procedures to manage the company and operate its business[115]. - The company has adopted the corporate governance code as per the listing rules and has complied with applicable code provisions during the year[116]. - The board meets at least four times a year to review the group's operational, financial, and business performance, including interim and annual financial results[121]. - The board has established a diversity policy that considers various perspectives, including gender, age, and professional experience when selecting director candidates[140]. - The company provides indemnification for directors and senior officers for liabilities incurred in the performance of their duties, except in cases of negligence or fraud[132]. Employee and Talent Management - The company is focused on optimizing its talent strategy, aiming to build a highly efficient team with professional capabilities and innovative spirit[12]. - The overall gender ratio of the group's employees, including senior management, is 51% male and 49% female as of December 31, 2024[145]. - The company has established various share incentive plans to provide equity-based incentives and rewards for eligible individuals[190]. - As of December 31, 2024, the company has a total of 870 employees, focusing on attracting and retaining talent to maintain business development capabilities[190]. Environmental and Social Responsibility - The group reported a significant reduction in gasoline consumption by 35.07% compared to 2023, with total greenhouse gas emissions amounting to 1,044.39 tons of CO2 equivalent for the year[173]. - The company made charitable donations amounting to RMB 2.13 million in the current year, compared to RMB 0.08 million in 2023[184]. - The company has identified risks and opportunities related to climate change and is enhancing its greenhouse gas emissions accounting and management[173]. - The company provided services to small and micro enterprises 1,051,162 times in 2024, emphasizing its commitment to supporting this sector[174].